Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride + potassium chloride + sodium acetate + sodium gluconate + magnesium chloride
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Sodium chloride + potassium chloride + sodium acetate + sodium gluconate + magnesium chloride is a balanced, isotonic intravenous multi-electrolyte solution marketed by Baxter as **Plasma-Lyte A** and **Plasma-Lyte 148**. It provides water plus sodium, potassium, magnesium, chloride, acetate, and gluconate for fluid and electrolyte replacement. Acetate and gluconate are metabolized with consumption of hydrogen ions, producing a metabolic alkalinizing effect. The solution is used as a source of water and electrolytes and as an alkalinizing agent, including for hydration associated with dehydration or electrolyte imbalance.
- Brand names
- Plasma-Lyte 148Plasma-Lyte148Plasma-Lyte-148Plasma-Lyte A
- Other names
- Multiple Electrolytes Injection, Type 1, USPMultiple Electrolytes Injection, Type 1, USP, pH 5.5Multiple Electrolytes Injection, Type 1, USP, pH 7.4
Beyond the preview
Go deeper on sodium chloride + potassium chloride + sodium acetate + sodium gluconate + magnesium chloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride + potassium chloride + sodium acetate + sodium gluconate + magnesium chloride.